HIF-2α target genes collectively promote numerous pro-oncogenic changes (e.g., cell proliferation, epithelial to mesenchymal transition (EMT), invasion/metastasis, angiogenesis, metabolic reprogramming, immune tolerance, and extracellular matrix degradation) linked to kidney cancer progression. This evidence concerns the gene EPAS1 and kidney cancer.